Novaliq Announces More than 50% Patients Enrolled in CyclASol(...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
HEIDELBERG, Germany and CAMBRIDGE, Mass., April 28, 2021 /PRNewswire-AsiaNet/ -- - Topline results expected in 2nd half 2021; 475 out of a 834 target patients randomized in ESSENCE-2- Enrollment for 12-month safety extension trial (ESSENCE-2 OLE) completed- Phase 2B/3 Trial ESSENCE-1 Published in Cornea: The Journal of Cor...
Authors: LATEST ASIANET NEWS RELEASES